Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian Jensen

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Bioinformatics (Oxford, England)|June 29, 2018
MARSI: metabolite analogues for rational strain improvementJoão G R Cardoso, Ahmad A Zeidan, Kristian Jensen, et al.
Microbiology Resource Announcements|April 2, 2021
Draft Genome Sequences of 3 Strains of Apilactobacillus kunkeei Isolated from the Bee Gut Microbial CommunityJulien Crovadore, Romain Chablais, François Raffini, et al.
European Urology|June 10, 2008
Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor blocker--results from a 1-yr, multicentre, randomised, phase 2 dosage-finding study in the treatment of prostate cancerHendrik Van Poppel, Bertrand Tombal, Jean J de la Rosette, et al.
Clinical Chemistry and Laboratory Medicine|June 22, 2012
Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responsesDavid Ulmert, Andrew J Vickers, Howard I Scher, et al.
Molecular Autism|April 3, 2024
Clinical correlates of diagnostic certainty in children and youths with Autistic DisorderEya-Mist Rødgaard, Borja Rodríguez-Herreros, Abderrahim Zeribi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2003
Expression of a novel murine type I IFN in the pancreatic islets induces diabetes in miceGalya Vassileva, Shu-Cheng Chen, Ming Zeng, et al.
Metabolism: Clinical and Experimental|May 20, 2017
siRNA-mediated inhibition of SREBP cleavage-activating protein reduces dyslipidemia in spontaneously dysmetabolic rhesus monkeysBeth Ann Murphy, Marija Tadin-Strapps, Kristian Jensen, et al.
Proteomics|June 10, 2004
Double chip protein arrays using recombinant single-chain Fv antibody fragmentsIlka Gilbert, Susanne Schiffmann, Susanne Rubenwolf, et al.
BJU International|November 28, 2008
The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancerLaurence Klotz, Laurent Boccon-Gibod, Neal D Shore, et al.
Journal of Hazardous Materials|May 31, 2024
Chemical mixture effects on the simplified human intestinal microbiota: Assessing xenobiotics at environmentally realistic concentrationsSven-Bastiaan Haange, Sarah Riesbeck, Alix Sarah Aldehoff, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Bioinformatics (Oxford, England)|June 29, 2018
MARSI: metabolite analogues for rational strain improvementJoão G R Cardoso, Ahmad A Zeidan, Kristian Jensen, et al.
Microbiology Resource Announcements|April 2, 2021
Draft Genome Sequences of 3 Strains of Apilactobacillus kunkeei Isolated from the Bee Gut Microbial CommunityJulien Crovadore, Romain Chablais, François Raffini, et al.
European Urology|June 10, 2008
Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor blocker--results from a 1-yr, multicentre, randomised, phase 2 dosage-finding study in the treatment of prostate cancerHendrik Van Poppel, Bertrand Tombal, Jean J de la Rosette, et al.
Clinical Chemistry and Laboratory Medicine|June 22, 2012
Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responsesDavid Ulmert, Andrew J Vickers, Howard I Scher, et al.
Molecular Autism|April 3, 2024
Clinical correlates of diagnostic certainty in children and youths with Autistic DisorderEya-Mist Rødgaard, Borja Rodríguez-Herreros, Abderrahim Zeribi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2003
Expression of a novel murine type I IFN in the pancreatic islets induces diabetes in miceGalya Vassileva, Shu-Cheng Chen, Ming Zeng, et al.
Metabolism: Clinical and Experimental|May 20, 2017
siRNA-mediated inhibition of SREBP cleavage-activating protein reduces dyslipidemia in spontaneously dysmetabolic rhesus monkeysBeth Ann Murphy, Marija Tadin-Strapps, Kristian Jensen, et al.
Proteomics|June 10, 2004
Double chip protein arrays using recombinant single-chain Fv antibody fragmentsIlka Gilbert, Susanne Schiffmann, Susanne Rubenwolf, et al.
BJU International|November 28, 2008
The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancerLaurence Klotz, Laurent Boccon-Gibod, Neal D Shore, et al.
Journal of Hazardous Materials|May 31, 2024
Chemical mixture effects on the simplified human intestinal microbiota: Assessing xenobiotics at environmentally realistic concentrationsSven-Bastiaan Haange, Sarah Riesbeck, Alix Sarah Aldehoff, et al.
Pageof 5